These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 3009794)
21. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. Ehlert FJ; Tran LP J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898 [TBL] [Abstract][Full Text] [Related]
22. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
23. Species difference in the muscarinic receptors of thoracic aorta. Yamanaka K; Hashimoto S; Muramatsu I J Pharmacol Exp Ther; 1986 Jun; 237(3):980-6. PubMed ID: 3754896 [TBL] [Abstract][Full Text] [Related]
24. Selective labelling of M1-receptors in autonomic ganglia with 3H-pirenzepine. Giraldo E; Monferini E; Hammer R Arzneimittelforschung; 1985; 35(1A):325-8. PubMed ID: 3838676 [TBL] [Abstract][Full Text] [Related]
25. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708 [TBL] [Abstract][Full Text] [Related]
27. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Nilvebrant L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114 [TBL] [Abstract][Full Text] [Related]
28. Pharmacologic characterization of muscarinic receptors of insect brains. Abdallah EA; Eldefrawi ME; Eldefrawi AT Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028 [TBL] [Abstract][Full Text] [Related]
30. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related]
31. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230 [TBL] [Abstract][Full Text] [Related]
32. Characterization of muscarinic receptors of the rabbit ear artery smooth muscle and endothelium. Hynes MR; Banner W; Yamamura HI; Duckles SP J Pharmacol Exp Ther; 1986 Jul; 238(1):100-5. PubMed ID: 3755169 [TBL] [Abstract][Full Text] [Related]
33. Propylbenzilylcholine mustard has greater specificity for muscarinic m2 receptors than for m3 receptors present in cerebellar granule cell culture from rat. McLeskey SW; Wojcik WJ J Pharmacol Exp Ther; 1992 Nov; 263(2):703-7. PubMed ID: 1432698 [TBL] [Abstract][Full Text] [Related]
34. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Flynn DD; Mash DC Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852 [TBL] [Abstract][Full Text] [Related]
35. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550 [TBL] [Abstract][Full Text] [Related]
36. Characterization of muscarinic receptors in human, guinea pig and rat lung. Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503 [TBL] [Abstract][Full Text] [Related]
37. Ontogeny of cortical muscarinic receptor subtypes and muscarinic receptor-mediated responses in rat. Lee W; Nicklaus KJ; Manning DR; Wolfe BB J Pharmacol Exp Ther; 1990 Feb; 252(2):482-90. PubMed ID: 2156047 [TBL] [Abstract][Full Text] [Related]
38. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ; Jenden DJ Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [TBL] [Abstract][Full Text] [Related]
39. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems. McKinney M; Anderson D; Vella-Rountree L Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467 [TBL] [Abstract][Full Text] [Related]
40. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells. Brown JH; Goldstein D; Masters SB Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]